On Jun. 26, 2015, The Keck School of Medicine announced it had established the University of Southern California Alzheimer’s Therapeutic Research Institute (USC ATRI), located in San Diego, CA. Distinguished Alzheimer’s disease scientist, Paul Aisen, M.D., was appointed founding director of USC ATRI.

Alzheimer’s disease is one of the top 10 leading causes of death in the U.S.. The 6th leading cause of death among US adults and the 5th leading cause of death among adults aged 65 years or older.

The establishment of the USC ATRI with Aisen as director adds a strong clinical research program to complement USC’s existing strengths in Alzheimer’s disease research.